ERVW-1 and myasthenia gravis: In the comprehensive analysis (illustrated in Figure 1), we observed a statistically significant presence of AAbs against HERV-K and HERV-W in the MG patient group when compared to the control group, except for the epitopes HERV-K-env-su(205–226) (Figure 1D) and HERV-K-env-su(161–180) (Figure 1G).